Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 196 AL 210

Risk of progression to Alzheimer's disease for different neuropsychological Mild Cognitive Impairment subtypes: A hierarchical meta-analysis of longitudinal studies

Oltra-Cucarella J, Ferrer-Cascales R, Alegret M, Gasparini R, Díaz-Ortiz LM, Ríos R, Martínez-Nogueras ÁL, Onandia I, Pérez-Vicente JA, Cabello-Rodríguez L, Sánchez-SanSegundo M.

Psychol Aging. 2018 Nov;33(7):1007-1021. doi: 10.1037/pag0000294. Epub 2018 Oct 4.

Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study

Harrison JE, Rentz DM, Brashear HR, Arrighi HM, Ropacki MT, Liu E.

J Prev Alzheimers Dis. 2018;5(4):236-244. doi: 10.14283/jpad.2018.31.

Effects of Meditation and Music-Listening on Blood Biomarkers of Cellular Aging and Alzheimer's Disease in Adults with Subjective Cognitive Decline: An Exploratory Randomized Clinical Trial

Innes KE, Selfe TK, Brundage K, Montgomery C, Wen S, Kandati S, Bowles H, Khalsa DS, Huysmans Z.

J Alzheimers Dis. 2018;66(3):947-970. doi: 10.3233/JAD-180164.

Coffee Consumption and Risk of Dementia and Alzheimer's Disease: A Dose-Response Meta-Analysis of Prospective Studies

Larsson SC, Orsini N.

Nutrients. 2018 Oct 14;10(10):1501. doi: 10.3390/nu10101501.

Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer Disease

Al-Dahhak R, Khoury R, Qazi E, Grossberg GT.

Clin Geriatr Med. 2018 Nov;34(4):617-635. doi: 10.1016/j.cger.2018.06.008. Epub 2018 Aug 21.

Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease

Florek L, Tiepolt S, Schroeter ML, Berrouschot J, Saur D, Hesse S, Jochimsen T, Luthardt J, Sattler B, Patt M, Hoffmann KT, Villringer A, Classen J, Gertz HJ, Sabri O, Barthel H.

J Alzheimers Dis. 2018;66(3):1105-1116. doi: 10.3233/JAD-180522.

Effect of dietary interventions in mild cognitive impairment: a systematic review

McGrattan AM, McEvoy CT, McGuinness B, McKinley MC, Woodside JV.

Br J Nutr. 2018 Dec;120(12):1388-1405. doi: 10.1017/S0007114518002945. Epub 2018 Nov 9.

Neuropsychiatric Symptoms Complicating the Diagnosis of Alzheimer's Disease: A Case Report

Eikelboom WS, van Rooij JGJ, van den Berg E, Coesmans M, Jiskoot LC, Singleton E, Ossenkoppele R, van Swieten JC, Seelaar H, Papma JM.

J Alzheimers Dis. 2018;66(4):1363-1369. doi: 10.3233/JAD-180700.

Contribution of Bilingualism to Cognitive Reserve of an Italian Literature Professor at High Risk for Alzheimer's Disease

Lombardi G, Polito C, Berti V, Bagnoli S, Nacmias B, Pupi A, Sorbi S.

J Alzheimers Dis. 2018;66(4):1389-1395. doi: 10.3233/JAD-180736.

Supporting breast cancer screening decisions for caregivers of older women with dementia: study protocol for a randomized controlled trial

Fowler NR, Schonberg MA, Sachs GA, Schwartz PH, Gao S, Lane KA, Inger L, Torke AM.

Trials. 2018 Dec 12;19(1):678. doi: 10.1186/s13063-018-3039-z.

Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis

Mueller C, Perera G, Hayes RD, Shetty H, Stewart R.

Age Ageing. 2018 Jan 1;47(1):88-94. doi: 10.1093/ageing/afx098.

Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer's Disease Treatment

De Matteis L, Martín-Rapún R, de la Fuente JM.

Curr Med Chem. 2018;25(35):4602-4615. doi: 10.2174/0929867324666171012112026.

Cognitive Training in Patients with Alzheimer's Disease: Findings of a 12-month Randomized Controlled Trial

Trebbastoni A, Imbriano L, Podda L, Rendace L, Sacchetti ML, Campanelli A, D'Antonio F, de Lena C.

Curr Alzheimer Res. 2018 Mar 14;15(5):452-461. doi: 10.2174/1567205014666171113105044.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias